Clinical trial
Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused…
NCT00089453 · University of Arkansas, Other · Completed
Key facts
| NCT number | NCT00089453 |
|---|---|
| Title | Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant |
| Official title | UARK 2003-18, A Phase II Study of KIR-Ligand Mismatched Haplo-Identical Natural Killer Cells Transfused Before Autologous Stem Cell Transplant in Relapsed Multiple Myeloma |
| Lead sponsor | University of Arkansas, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug, Procedure |
| Interventions | Dexamethasone, Cyclophosphamide, Melphalan, Fludarabine, Bortezomide, Leukapheresis, Interleukin, Infusion #1, Leukapheresis #2, Infusion #2 and 1 more |
| Enrollment | 10 |
| Start date | Sep 1, 2003 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Aug 6, 2004 |
| Last update posted | Apr 19, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: